Showing 201 - 220 results of 100,447 for search '(( 10 ng decrease ) OR ( 5 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.22s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206
  7. 207
  8. 208

    Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients by Stuart A. Savill (3129060)

    Published 2016
    “…The change in expression in HMW isoforms from TPM1 and TPM4 was replicated in THP1 cells treated with 1 ng/ml TNFα (0.10 and 0.12 v 1.00 respectively) or 10 ng/ml IL-1α (0.17 and 0.14 v 1.00 respectively). …”
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214

    Decrease in cell viability by siRNA and miRNA dependent induction of DTA. by Liraz Harel (675561)

    Published 2014
    “…<p>U251 cells were transfected with the indicated construct (50 ng) with (A) or without (B) siRNAs (10pmol). Cell viability was determined by an XTT assay. …”
  15. 215
  16. 216

    IGFBP-3 decreases vascular tone by activating scavenger receptor-B1. by Yagna P. R. Jarajapu (316562)

    Published 2013
    “…A significant decrease in myogenic tone was observed at 100 (*P<0.02, n = 5) and 300 ng/ml (**P<0.01, n = 5) IGFBP-3. …”
  17. 217
  18. 218

    Delphinidin alters VEGF-A splicing to increase VEGF-A<sub>165</sub>b and decrease total VEGF-A expression. by Megan Stevens (3964886)

    Published 2019
    “…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A<sub>165</sub>b relative to total VEGF-A<sub>165</sub> (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A<sub>165</sub>b before stripping and reprobing with panVEGF-A). …”
  19. 219
  20. 220

    Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

    Published 2011
    “…</p> Human primary cells and human and mouse established cell lines were treated with (TGF-β1) or without (control) 5 ng/ml TGF-β1 for 48 hours. The cells were then harvested and incubated with propidium iodide, and DNA content was determined using a FACS Caliber (Becton-Dickinson). …”